Health Care & Life Sciences » Biotechnology | Bioblast Pharma Ltd.

Bioblast Pharma Ltd.

Bioblast Pharma Ltd.
Stock Exchange NASDAQ Stock Market
EPS
$1.79
Market Cap
$4.11 M
Shares Outstanding
3.34 M
Public Float
1.6 M

Profile

Address
37 Dereh Menachem Begin Street
Tel Aviv TA 6522042
Israel
Employees -
Website http://www.bioblastpharma.com
Updated 09/14/2018
Bioblast Pharma Ltd. operates as a clinical development-stage biopharmaceutical company. It focuses on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic diseases. The company also focuses on diseases with severe and debilitating manifestations, where the unmet medical need is clear, the biological mechanism of action is understood, and for which there is no satisfactory treatment.

Financials

View All
Created with Highcharts 5.0.14Bioblast Pharma Ltd.Net Income. Fiscal year is January-December. All values USD Thousands.1 1451 1457 0227 02215 36515 36516 02216 0225 9455 9452013201420152016201705k10k15k20k

Dalia Megiddo
Director, Chief Executive & Medical Officer
Ran Weinstock
Independent Director